小青龙汤加减联合孟鲁司特治疗小儿咳嗽变异性哮喘的临床分析

Treating children with cough variant asthma with the Xiao Qinglong decoction plus montelukast

目的:研究和探讨小青龙汤加减联合孟鲁司特治疗小儿咳嗽变异性哮喘的临床效果。方法:收集2013年1月-2014年6月来我院门诊就诊的小儿咳嗽变异性哮喘100例,随机分为观察组与对照组各50例,对照组给予孟鲁司特纳片,每次4mg,1次/d,每天晚上睡前口服;观察组在对照组基础上联合小青龙汤加减口服,两个星期为1个疗程。观察和对比两组患者治疗前后的症状变化情况。结果:观察组有效率为94%,对照组有效率为76%,两组对比差异有统计学意义(P<0.05);观察组复发率为6%,对照组复发率为28%,两组对比差异有统计学意义(P<0.05)。结论:小青龙汤加减联合孟鲁司特治疗小儿咳嗽变异性哮喘较单用孟鲁司特有效率高,复发率低,临床效果显著,值得推广。

Objective： To study and explore the Xiao Qinglong decoction plus montelukast for children with cough variant asthma. Methods： 100 children were randomly divided into two groups; 50 patients in the control group was given montelukast turner; the observation group were given the Xiao Qinglong decoction more, for a course. Results： In the observation group, the efficiency was 94%; in control group, it was 76%（P〈0.05）; the recurrence rate was 6% in the observation group; in the control group, it was 28%（P〈0.05）. Conclusion： The Xiao Qinglong decoction plus montelukast for cough variant asthma was better than single application of montelukast, with high efficiency and low recurrence rate, a significant clinical effect, is worthy of promotion.